Influenza HA (307-319) is 13 amino acids 307 to 319 fragment of Influenza HA. Influenza HA is a glycoprotein found on the surface of influenza viruses.
Influenza HA 307-319 is a synthetic peptide fragment corresponding to amino acids 307 through 319 of the hemagglutinin (HA) protein from the influenza virus. As a defined epitope within the HA protein, this peptide plays a significant role in studies of viral entry, host immune recognition, and antigenic variation. Its sequence represents a highly conserved region that is often implicated in the virus's ability to bind host cells and mediate membrane fusion, making it particularly relevant for research into influenza pathogenesis, immune response mechanisms, and vaccine antigen design. The availability of this peptide in a purified and sequence-defined form enables precise experimental manipulation and facilitates a wide range of biochemical and immunological investigations.
Epitope mapping: Researchers frequently employ the Influenza HA 307-319 peptide to map B-cell and T-cell epitopes recognized during infection or following immunization. By incorporating this defined sequence into immunoassays such as ELISA or peptide microarrays, investigators can determine the specificity and breadth of antibody responses or T-cell activation. This approach is essential for dissecting immune recognition patterns, identifying immunodominant regions within the HA protein, and informing the rational design of next-generation influenza vaccines.
Antigen presentation studies: The peptide serves as a valuable tool for investigating antigen processing and presentation pathways, particularly in the context of MHC class II molecules. Because it represents a naturally processed segment of the HA protein, it can be used to pulse antigen-presenting cells or to load onto MHC molecules in vitro, enabling the study of peptide-MHC interactions, T-cell receptor specificity, and the cellular mechanisms underlying adaptive immunity to influenza. Such studies are critical for elucidating the determinants of protective immunity and for evaluating candidate vaccine formulations.
Vaccine research and development: The defined sequence of HA 307-319 makes it a strategic component in the development and evaluation of peptide-based vaccine candidates. By incorporating this peptide into experimental vaccine formulations or using it as a reference antigen in immunogenicity assays, researchers can assess the ability of vaccine constructs to elicit targeted immune responses. These efforts contribute to the optimization of immunogen design, the assessment of cross-reactivity among influenza strains, and the development of broadly protective influenza vaccines.
Protein-protein interaction analysis: The peptide is also employed in studies aimed at characterizing the molecular interactions between viral HA and host cell receptors or neutralizing antibodies. By using peptide binding assays, surface plasmon resonance, or co-crystallization experiments, scientists can dissect the structural and functional determinants of HA-mediated host cell entry. Insights gained from these analyses support the identification of novel antiviral targets and the rational design of entry inhibitors.
Structural and biophysical studies: Influenza HA 307-319 is utilized as a model system for examining the conformational properties of HA-derived sequences in solution or in complex with other biomolecules. Techniques such as circular dichroism spectroscopy, NMR, or X-ray crystallography can be applied to this peptide to elucidate secondary structure, flexibility, and interaction interfaces. Such structural insights are fundamental for understanding the molecular basis of viral infectivity, immune recognition, and the development of structure-guided interventions against influenza.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More